2024 annual financial data
Marker Therapeutics 2024 Financial results
Direct answer
Revenue was 6,591,080 USD.
Operating income was -11,118,372 USD and net income was -10,731,315 USD.
Operating cash flow was -10,910,324 USD.
Get free Marker Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,591,080 USD
- Operating income
- -11,118,372 USD
- Net income
- -10,731,315 USD
- Operating cash flow
- -10,910,324 USD
Explore related company data
View all 2024 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Marker Therapeutics financial years